title: A high-performance liquid chromatography-electrospray-tandem mass spectrometry analysis of cortisol and metabolites in placental perfusate.
abstract: A reversed-phase high-performance liquid chromatography-electrospray-tandem mass spectrometry assay (HPLC-ESI-MS/MS) was developed to quantitate cortisol, cortisone, 20 alpha- and beta-dihydrocortisol, 20 alpha- and beta-dihydrocortisone, tetrahydrocortisol, and tetrahydrocortisone. The technique was used to analyze perfusate from the isolated human placental lobule for cortisol and its metabolites. Analytes were prepared from the perfusion medium using C18 solid-phase extraction cartridges. The internal standard for the analyses was 6 alpha-methylprednisolone. Chromatography was performed on a Novapak C18 column at ambient temperature using 53% methanol and 47% 10 mM ammonium formate buffer (pH 4.0) as mobile phase, at a flow rate of 80 microL/min. A PE-SCIEX API III triple quadrupole instrument was used for mass spectrometric detection. An ionspray (pneumatically assisted electrospray) interface was used in negative and positive ionization mode. The assay was linear over the range 100-2000 micrograms/L for each analyte. The instrumental limit of detection was 50 pg. Assay imprecision at 400 and 800 micrograms/L was < or = 10% (total coefficient of variation). Accuracy ranged between 83.2% for 20 beta-dihydrocortisone to 102.6% for cortisone. Recovery of 1000 micrograms/L analyte ranged from 91.3% for cortisone to 109.7% for tetrahydrocortisol.
authors.affiliation: Department of Medicine, Princess Alexandra Hospital, University of Queensland, Brisbane, Australia. hdodds@gpo.pa.uq.oz.au
authors.forename: H M
authors.initials: HM
authors.lastname: Dodds
authors.forename: P J
authors.initials: PJ
authors.lastname: Taylor
authors.forename: G R
authors.initials: GR
authors.lastname: Cannell
authors.forename: S M
authors.initials: SM
authors.lastname: Pond
mesh_terms: D042842:11-beta-Hydroxysteroid Dehydrogenases; D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D003348:Cortisone / Q000031:analogs & derivatives / Q000032:analysis / Q000378:metabolism; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000031:analogs & derivatives / Q000032:analysis* / Q000378:metabolism; D006913:Hydroxysteroid Dehydrogenases / Q000037:antagonists & inhibitors; D066298:In Vitro Techniques; D013058:Mass Spectrometry / Q000379:methods*; D010477:Perfusion; D010920:Placenta / Q000737:chemistry* / Q000378:metabolism; D011247:Pregnancy; D013760:Tetrahydrocortisol / Q000032:analysis / Q000378:metabolism; D013761:Tetrahydrocortisone / Q000032:analysis / Q000378:metabolism
chemical_list: C016499:20-hydroxycortisol; C005674:4-pregnene-17 alpha,20 beta,21-triol-3,11-dione; D013761:Tetrahydrocortisone; D013760:Tetrahydrocortisol; D006913:Hydroxysteroid Dehydrogenases; D042842:11-beta-Hydroxysteroid Dehydrogenases; D003348:Cortisone; D006854:Hydrocortisone